[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
The study was concerned with evaluation of the diagnostic potential of positron emission tomography (PET) with 18-FDG in clinical oncology and elucidation of its role in assessing therapy effectiveness. The Ecat Exact 47 and Ecat Exat HR+ (Siemens) insatllations were used to examine 674 patients, with Whole Body protocol used in 585. PET with 18-FDG proved highly effective in diagnosing malignancies of the breast, lung, liver, pancreas, testis, brain and lymphoma as well as evaluating the efficacy of therapy.
Granov
A M
AM
Central Research Institute of Roentgeno-Radiology, Ministry of Health of the RF, St. Petersburg.
Tiushin
L A
LA
Tlostanova
M S
MS
Kostenikov
N A
NA
Ryzhkova
D V
DV
Savello
V E
VE
Stanzhevskiĭ
A A
AA
D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D001943:Breast Neoplasms / Q000000981:diagnostic imaging; D002250:Carbon Radioisotopes; D003937:Diagnosis, Differential; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008223:Lymphoma / Q000000981:diagnostic imaging; D008297:Male; D008495:Medical Oncology / Q000379:methods*; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D017063:Outcome Assessment, Health Care; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D013736:Testicular Neoplasms / Q000000981:diagnostic imaging; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods
D002250:Carbon Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18